Recruitment of participants into the largest lung cancer screening study in Europe has been completed with a total 13,035 taking part.
The Princess Royal has officially opened the new UCL Eastman Dental Institute (EDI) facilities and been shown around the EDI’s new Clinical Research suite by BRC Oral Health & Disease Theme Lead Professor Stefano Fedele.
UCLH is participating in the first Covid-19 vaccine study in the UK to recruit pregnant women.
UCLH is part of study announced by the Health Secretary in which volunteers will receive a third ‘booster’ Covid-19 vaccine.
UCLH is to mark International Clinical Trials Day on 20 May, which this year coincides with the National Institute for Health Research (NIHR) campaign encouraging everyone to ‘Be Part of Research.’
UCLH Director of Research and Director of the UCLH BRC Professor Bryan Williams has received an award for outstanding contributions to research in the field of hypertension (high blood pressure) from the World Hypertension League (WHL) and World Health Organisation.
The UCLH BRC has released its latest film about biomedical research, looking at how scientists are using DNA to find the causes of currently untreatable diseases and develop new drug treatments for them.
Over 1000 breathing aids developed by UCLH and UCL have been sent to India to help with the surge in Covid-19 cases.
UCLH Director of Research Professor Bryan Williams and Consultant Neuropsychologist at UCLH Professor Lisa Cipolotti have been elected Fellows of the Academy of Medical Sciences.
Mild Covid-19 infection is very unlikely to cause lasting damage to the structure or function of the heart, according to a study supported by UCLH.
A pioneering study by UCL scientists supported by the UCLH BRC has discovered the presence of a harmful inflammatory protein in patients with symptomatic tuberculosis (TB).
The UCLH BRC is part of a new working group established by the Department of Health and Social Care (DHSC) to improve research on hearing loss and tinnitus.
UCLH is to lead an initiative to improve care for myeloma patients alongside Oxford University Hospitals NHS Foundation Trust and University Hospital Southampton NHS Foundation Trust.
Researchers at UCLH have begun a study which could set the foundations for how booster COVID-19 vaccinations are delivered in the future.
UCLH is one of the first sites in the UK to recruit more than 100 participants to undergo dedicated research visits for a national study looking at the long-term impacts of Covid-19 after hospitalisation for the disease.